Surgeon and Scientist Cliona’s Marathon Challenge

Breast cancer reconstructive surgeon and one of our lead clinical researchers, Cliona Kirwan, is taking on the incredible challenge of running this year’s Lakeland Marathon.

The Lakeland Marathon takes place in the heart of the Peak District and is one of the most gruelling marathon’s you could take on.

Cliona is taking on this challenge whilst working up to 60 hours a week. She is planning on training around her already busy work/life balance training before and after work. You may even see her running to and from the Nightingale Centre with her rucksack on! Cliona is raising funds to help support the vital research that Genesis are carrying out to make breast cancer a preventable disease for future generations.

About Cliona:

Cliona is part of the consultant breast surgery team, performing cancer and prevention surgery and breast reconstruction at UHSM. In addition to this, she does breast cancer research at the new Manchester Cancer Research Centre. Here she leads a group of scientists who are studying how the blood clotting system may help breast cancer grow and spread. This could lead to new ways of detecting or monitoring breast cancer. More excitingly, this could lead to new treatments. Cliona is also the Chair of our [Genesis] Scientific Advisory Board, and helps us decide which areas of research are the biggest priority to fund. She has decided to take on this incredibly tough challenge because she wants Genesis to be able to fund many more important research studies, so that we can meet our aim of preventing breast cancer.

About Cliona’s Genesis-Funded Research Project:

DCIS is very early cancer which occurs in the milk ducts of the breast. These cells are all contained inside the ducts and have not started to spread into the surrounding breast tissue.

– We hope to determine if the cells that cause clotting make DCIS cells behave like invasive breast cancer cells, and make normal cells act like DCIS cells.
– We hope to determine if anti-clotting drugs slow or stops the progression of normal cells into DCIS cells, and DCIS cells into invasive cancer cells.

We hope that if the results from this study and further studies are promising, this will lead to patient trials of drugs that may halt the progression of DCIS.

Why not support Cliona with her challenge and visit: